Koumiss consumption modulates gut microbiota, increases plasma high density cholesterol, decreases immunoglobulin G and albumin

Journal of Functional Foods

Volumn 52, Issue , 2019, Pages 469-478

  Hou, Qiangchuan ^a   Li, Changkun ^a   Liu, Yahua ^a   Li, Weicheng ^a   Chen, Yongfu ^a   Siqinbateer, ^b   Bao, Yingshu ^b   saqila, Wu ^b   Zhang, Heping ^a   Menghe, Bilige ^a   Sun, Zhihong ^a  

^a INNER MONGOLIA AGRICULTURAL UNIVERSITY   (China)

^b Inner Mongolia Xilin Gol League Mongolian Hospital   (China)

Author keywords

Gut microbiota; Hyperlipidemia; Koumiss; Metabolomics; PacBio SMRT sequencing

Indexed keywords

EID: 85057122809     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2018.11.023     Document Type: Article

References (67)

1. Abliz, A., Aji, Q., Abdusalam, E., Sun, X., Abdurahman, A., Zhou, W., Umar, A., Effect of Cydonia oblonga Mill. leaf extract on serum lipids and liver function in a rat model of hyperlipidaemia. Journal of Ethnopharmacology 151:2 (2014), 970–974.
2. Abrahamsson, T.R., Jakobsson, H.E., Andersson, A.F., Bjorksten, B., Engstrand, L., Jenmalm, M.C., Low gut microbiota diversity in early infancy precedes asthma at school age. Clinical & Experimental Allergy 44:6 (2014), 842–850.
3. Aderiye, B., Laleye, S., Odeyemi, A., Hypolipidemic potential of Lactobacillus and Streptococcus sp. from some Nigerian fermented foods. Philosophy and Phenomenological Research. J. Microbiol. 2:6 (2007), 538–544.
4. Alberti, G. (2005). Introduction to the metabolic syndrome. 7(suppl_D), D3–D5.
5. Amir, A., Zeisel, A., Zuk, O., Elgart, M., Stern, S., Shamir, O., Shental, N., High-resolution microbial community reconstruction by integrating short reads from multiple 16S rRNA regions. Nucleic Acids Research, 41(22), 2013, e205.
6. Apostolidis, E., Kwon, Y.I., Ghaedian, R., Shetty, K., Fermentation of milk and soymilk by Lactobacillus bulgaricus and Lactobacillus acidophilus enhances functionality for potential dietary management of hyperglycemia and hypertension. Food Biotechnology 21:3–4 (2007), 217–236.
7. Arifin, S.A., Falasca, M., Lysophosphatidylinositol signalling and metabolic diseases. Metabolites, 6(1), 2016, 6.
8. Asbach, P., Paetsch, I., Stawowy, P., Sander, B., Fleck, E., Statin-associated focal myositis. International Journal of Cardiology 133:1 (2009), e33–e34.
9. Bakir, B., Sari, E., Aydin, B., Yildiz, S., Immunohistochemical examination of effects of kefir, koumiss and commercial probiotic capsules on platelet derived growth factor-c and platelet derived growth factor receptor-alpha expression in mouse liver and kidney. Biotechnic & Histochemistry 90:3 (2015), 190–196.
10. Begley, M., Hill, C., Gahan, C.G., Bile salt hydrolase activity in probiotics. Applied and Environmental Microbiology 72:3 (2006), 1729–1738.
11. Benjamini, Y., Yekutieli, D., The control of the false discovery rate in multiple testing under dependency. Annals of Statistics, 2001, 1165–1188.
12. Caporaso, J.G., Bittinger, K., Bushman, F.D., DeSantis, T.Z., Andersen, G.L., Knight, R., PyNAST: A flexible tool for aligning sequences to a template alignment. Bioinformatics 26:2 (2010), 266–267.
13. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Gordon, J.I., QIIME allows analysis of high-throughput community sequencing data. Nature Methods 7:5 (2010), 335–336.
14. Catapano, A.L., Graham, I., De Backer, G., Wiklund, O., Chapman, M.J., Drexel, H., Landmesser, U., 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis, 253, 2016, 281.
15. Chatelier, E.L., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Kennedy, S., Richness of human gut microbiome correlates with metabolic markers. Nature 500:7464 (2013), 541–546.
16. Chen, H., Miao, H., Feng, Y.-L., Zhao, Y.-Y., & Lin, R.-C. (2014). Metabolomics in dyslipidemia Advances in Clinical Chemistry (Vol. 66, pp. 101–119): Elsevier.
17. Chong, I.G., Jun, C.H., Performance of some variable selection methods when multicollinearity is present. Chemometrics and Intelligent Laboratory Systems 78:1–2 (2005), 103–112.
18. Cole, J.R., Chai, B., Farris, R.J., Wang, Q., Kulam-Syed-Mohideen, A.S., McGarrell, D.M., Tiedje, J.M., The ribosomal database project (RDP-II): Introducing myRDP space and quality controlled public data. Nucleic Acids Research 35:suppl_1 (2007), D169–D172.
19. Courtin, P., Nardi, M., Wegmann, U., Joutsjoki, V., Ogier, J.C., Gripon, J.C., Monnet, V., Accelerating cheese proteolysis by enriching Lactococcus lactis proteolytic system with lactobacilli peptidases. International Dairy Journal 12:5 (2002), 447–454.
20. Dati, F., Schumann, G., Thomas, L., Aguzzi, F., Baudner, S., Bienvenu, J., Hyltoft-Petersen, P., Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP reference material (CRM 470). European Journal of Clinical Chemistry and Clinical Biochemistry 34:6 (1996), 517–520.
21. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Fischbach, M.A., Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:7484 (2014), 559–563.
22. DeSantis, T.Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E.L., Keller, K., Andersen, G.L., Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Applied and Environmental Microbiology 72:7 (2006), 5069–5072.
23. Dönmez, N., Kısadere, İ., Balaban, C., Kadiralieva, N., Effects of traditional homemade koumiss on some hematological and biochemical characteristics in sedentary men exposed to exercise. Biotechnic & Histochemistry 89:8 (2014), 558–563.
24. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26:19 (2010), 2460–2461.
25. Gregory, J.C., Buffa, J.A., Org, E., Wang, Z., Levison, B.S., Zhu, W., Hazen, S.L., Transmission of atherosclerosis susceptibility with gut microbial transplantation. Journal of Biological Chemistry 290:9 (2015), 5647–5660.
26. Gutmann, A., Wagner, J.W., Moral science and the presidential commission for the study of bioethical issues. Lancet 379:9813 (2012), e20–e21.
27. Haas, B.J., Gevers, D., Earl, A.M., Feldgarden, M., Ward, D.V., Giannoukos, G., Sodergren, E., Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Research 21:3 (2011), 494–504.
28. He, K., Hu, Y., Ma, H., Zou, Z., Xiao, Y., Yang, Y., Ye, X., Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways. BBA – Molecular Basis of Disease 1862:9 (2016), 1696–1709.
29. Hou, Q.C., Xu, H.Y., Zheng, Y., Xi, X.X., Kwok, L.Y., Sun, Z.H., Zhang, W.Y., Evaluation of bacterial contamination in raw milk, ultra-high temperature milk and infant formula using single molecule, real-time sequencing technology. Journal of Dairy Science 98:12 (2015), 8464–8472.
30. Insull, W. Jr, Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: A scientific review. Southern Medical Journal 99:3 (2006), 257–274.
31. Kanjan, P., Hongpattarakere, T., Antibacterial metabolites secreted under glucose-limited environment of the mimicked proximal colon model by lactobacilli abundant in infant feces. Applied Microbiology & Biotechnology 100:17 (2016), 7651–7664.
32. Kelly, T.N., Bazzano, L.A., Ajami, N.J., He, H., Zhao, J., Petrosino, J.F., He, J., Gut microbiome associates with lifetime cardiovascular disease risk profile among bogalusa heart study participants. Circulation Research 119:8 (2016), 956–964.
33. Kim, C.H., Mitchell, J.B., Bursill, C.A., Sowers, A.L., Thetford, A., Cook, J.A., Davies, M.J., The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE/ mice. Atherosclerosis 240:1 (2015), 234–241.
34. Kowalczyk, M., Mayo, B., Fernández, M., Aleksandrzak-Piekarczyk, T., Updates on Metabolism in Lactic Acid Bacteria in Light of “Omic” Technologies. 2015, John Wiley & Sons Ltd, Technologies.
35. Krištić J., Vučković F., Menni, C., Klarić L., Keser, T., Beceheli, I., Sciences, M., Glycans are a novel biomarker of chronological and biological ages. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences 69:7 (2013), 779–789.
36. Kuang, Y.S., Lu, J.H., Li, S.H., Li, J.H., Yuan, M.Y., He, J.R., Qiu, L., Connections between the human gut microbiome and gestational diabetes mellitus. GigaScience 6:8 (2017), 1–12.
37. Kurdi, P., van Veen, H.W., Tanaka, H., Mierau, I., Konings, W.N., Tannock, G.W., Yokota, A., Cholic acid is accumulated spontaneously, driven by membrane delta pH, many lactobacilli. Journal of Bacteriology 182:22 (2000), 6525–6528.
38. Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: Human gut microbes associated with obesity. Nature 444:7122 (2006), 1022–1023.
39. Li, H., Qiu, T., Huang, G., Cao, Y., Production of gamma-aminobutyric acid by Lactobacillus brevis NCL912 using fed-batch fermentation. Microbial Cell Factories, 9(1), 2010, 85, 10.1186/1475-2859-9-85.
40. Lieber, C.S., S-adenosyl-L-methionine: Its role in the treatment of liver disorders. American Journal of Clinical Nutrition 76:5 (2002), 1183S–1187S.
41. Liu, W., Zheng, Y., Kwok, L.-Y., Sun, Z., Zhang, J., Guo, Z., Zhang, H., High-throughput sequencing for the detection of the bacterial and fungal diversity in Mongolian naturally fermented cow's milk in Russia. BMC Microbiology, 15(1), 2015, 45.
42. Lozupone, C., Knight, R., UniFrac: A new phylogenetic method for comparing microbial communities. Applied and Environmental Microbiology 71:12 (2005), 8228–8235.
43. Lu, S.C., Huang, Z.Z., Yang, H., Mato, J.M., Avila, M.A., Tsukamoto, H., Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. American Journal of Physiology-Gastrointestinal and Liver Physiology 279:1 (2000), G178–G185.
44. Matsui, T., Sato, M., Tanaka, M., Yamada, Y., Watanabe, S., Fujimoto, Y., Matsumoto, K., Vasodilating dipeptide Trp-His can prevent atherosclerosis in apo E-deficient mice. British Journal of Nutrition 103:3 (2010), 309–313.
45. Monjanarl, G., Zambonelli, C., Grazia, L., Kamecheva, G.K., Shigaeva, M., Saccharomyces unisporus as the principal aleoholic fermentation microorganism of traditional koumiss. Journal of Dairy Research 63:2 (1996), 327–331.
46. Mosher, J.J., Bernberg, E.L., Shevchenko, O., Kan, J., Kaplan, L.A., Efficacy of a 3rd generation high-throughput sequencing platform for analyses of 16S rRNA genes from environmental samples. Journal of Microbiological Methods 95:2 (2013), 175–181.
47. Murri, M., Leiva, I., Gomez-Zumaquero, J.M., Tinahones, F.J., Cardona, F., Soriguer, F., Queipo-Ortuño, M.I., Gut microbiota in children with type 1 diabetes differs from that in healthy children: A case-control study. BMC Medicine, 11(1), 2013, 46.
48. Narushima, S., Itoha, K., Miyamoto, Y., Park, S.H., Nagata, K., Kuruma, K., Uchida, K., Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria. Lipids 41:9 (2006), 835–843.
49. Ngongang, E.F.T., Tiencheu, B., Achidi, A.U., Fossi, B.T., Shiynyuy, D.M., Womeni, H.M., François, Z.N., Effects of probiotic bacteria from yogurt on enzyme and serum cholesterol levels of experimentally induced hyperlipidemic Wistar Albino rats. International Journal of Food Science and Agricultural Chemistry 1:3 (2016), 18–25.
50. Oguro, Y., Nishiwaki, T., Shinada, R., Kobayashi, K., Kurahashi, A., Metabolite profile of koji amazake and its lactic acid fermentation product by Lactobacillus sakei UONUMA. Journal of Bioscience and Bioengineering 124:2 (2017), 178–183.
51. Pan, D.D., Zeng, X.Q., Yan, Y.T., Characterisation of Lactobacillus fermentum SM-7 isolated from koumiss, a potential probiotic bacterium with cholesterol-lowering effects. Journal of the Science of Food and Agriculture 91:3 (2011), 512–518.
52. Price, M.N., Dehal, P.S., Arkin, A.P., FastTree: Computing large minimum evolution trees with profiles instead of a distance matrix. Molecular Biology and Evolution 26:7 (2009), 1641–1650.
53. Sanaa A Ali, M. A. H., Nagy Saba El Rigal. (2013). Impact of β-alanyl-L-histidine against Hypercholesterolemia. Journal of Pharmacology and Toxicological Studies, 1(2), 21–32.
54. Sefi, M., Fetoui, H., Makni, M., Zeghal, N., Mitigating effects of antioxidant properties of Artemisia campestris leaf extract on hyperlipidemia, advanced glycation end products and oxidative stress in alloxan-induced diabetic rats. Food and Chemical Toxicology 48:7 (2010), 1986–1993.
55. Stein, E.A., Lane, M., Comparison of statins in hypertriglyceridemia. The American Journal of Cardiology 81:4 (1998), 66B–69B.
56. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:7122 (2006), 1027–1031.
57. Uniacke-Lowe, T., Huppertz, T., Fox, P.F., Equine milk proteins: Chemistry, structure and nutritional significance. International Dairy Journal 20:9 (2010), 609–629.
58. Walsh, A.M., Crispie, F., Kilcawley, K., O'Sullivan, O., O'Sullivan, M.G., Claesson, M.J., Cotter, P.D., Microbial succession and flavor production in the fermented dairy beverage kefir. Msystems 1:5 (2016), e00052–00016.
59. Wang, J., Zhang, H., Chen, X., Chen, Y., Menghebilige, Bao, Q., Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet. Journal of Dairy Science 95:4 (2012), 1645–1654.
60. Wickham, H., ggplot2: Elegant graphics for data analysis. 2016, Springer.
61. Yao, G., Yu, J., Hou, Q., Hui, W., Liu, W., Kwok, L.-Y., Zhang, W., A perspective study of koumiss microbiome by metagenomics analysis based on single-cell amplification technique. Frontiers in Microbiology, 8, 2017, 165.
62. Yu, H., Qiu, H., Pan, J., Wang, S., Bao, Y., Jia, W.J.I.M., Hashimoto's thyroiditis concomitant with sequential autoimmune hepatitis, chorea and polyserositis: A new entity of autoimmune polyendocrine syndrome?. Internal Medicine 52:2 (2013), 255–258.
63. Yuan, H.D., Kim, S.J., Quan, H.Y., Huang, B., Chung, S.H., Ginseng leaf extract prevents high fat diet-induced hyperglycemia and hyperlipidemia through AMPK activation. Journal of Ginseng Research 34:4 (2010), 369–375.
64. Zareian, M., Ebrahimpour, A., Bakar, F.A., Mohamed, A.K., Forghani, B., Ab-Kadir, M.S., Saari, N., A glutamic acid-producing lactic acid bacteria isolated from Malaysian fermented foods. International Journal of Molecular Sciences 13:5 (2012), 5482–5497.
65. Zhang, A., Sun, H., Dou, S., Sun, W., Wu, X., Wang, P., Wang, X., Metabolomics study on the hepatoprotective effect of scoparone using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Analyst 138:1 (2013), 353–361.
66. Zhang, Y.J., Li, S., Gan, R.Y., Zhou, T., Xu, D.P., Li, H.B., Impacts of gut bacteria on human health and diseases. International Journal of Molecular Sciences, 16(4), 2015, 7493.
67. Zheng, X., Guiding principle of clinical research on new drugs of traditional Chinese medicine. 2002, China Medic-Pharmaceutical Sciences and Technology Publishing House, Beijing, 143.